Malvern Panalytical’s new Aeris: a compact XRD system making a big impact
February 23, 2021
Almelo, the Netherlands: Malvern Panalytical, a leading analytical instruments and services supplier, today launches a new version of its Aeris compact X-ray diffractometer (XRD). Aeris is a small-footprint system with a big heart, and even bigger ambitions. This new version contains capabilities previously only seen in much larger systems, powering exciting leaps forward in scientific [...]
February 23, 2021
A new Fast Trak lab will be established in the Genome Valley to provide flexibility for Biopharma scale up, professional training, technology evaluation, consultancy services and infrastructure support for process development. Part of Government of Telangana’s focus on life sciences in India’s growing economy. Cytiva, a global life science leader, and the State of Telangana [...]
BC Platforms Partners with Genomenon to Boost Rare Disease Diagnostics and Research
February 23, 2021
Genomenon’s ‘Mastermind’ AI-driven Genomic Search Engine combined with both BC Platforms’ Personalized Medicine BC|GENOME and Research and Discovery BC|INSIGHT Platforms BC Platforms, a global leader in healthcare data management, analytics and access announced that it has entered a collaboration with AI-driven genomics company, Genomenon (Ann Arbor, Michigan USA). The partnership is focused on two fronts. [...]
February 23, 2021
PARIS and SOUTH SAN FRANCISCO, Calif.: DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel “Click” chemistry commercialized by baseclick. In effect, this agreement enables DNA Script’s customers to enzymatically synthesize high purity nucleic acids [...]
February 23, 2021
SEATTLE -- Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID). This funding will fuel the commercialization of a first-in-class solution for the discovery of DNA viruses, employing a novel reagent kit and [...]
Battery Ventures-backed SPT Labtech acquires Apricot Designs and BioMicroLab
February 23, 2021
New acquisitions expand SPT Labtech’s laboratory automation solutions for the life sciences industry Battery Ventures, a global, technology-focused investment firm, recently completed the acquisitions of Apricot Designs ("Apricot") and BioMicroLab ("BML"), integrating the two companies into its sample-preparation platform company SPT Labtech. Terms of the transactions were not disclosed. Representing the third and fourth acquisitions [...]
February 23, 2021
Rockville, MD -- Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology from 10x Genomics, a life science [...]
Newcells Biotech secures over £5m for 3D tissue models
February 23, 2021
Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. The funding comes from two existing backers. Mercia has invested from its Northern Venture Capital Trust (VCT) and EIS funds and the North East Venture Fund (NEVF), which is [...]
QIAGEN expands Supervisory Board with appointment of a new member
February 22, 2021
Thomas Ebeling appointed to the Supervisory Board Venlo, the Netherlands – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and consumer goods industries, as a member of the Supervisory Board with immediate effect. Mr. Ebeling joins QIAGEN as part [...]
PerkinElmer Provides an Update on Valencia Branch Laboratory’s Accreditation Process
February 22, 2021
WALTHAM, Mass. -- PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department of Public Health (CDPH). The VBL started operations on November 1, 2020, and Laboratory Field Services (LFS) performed [...]
